Breaking News Instant updates and real-time market news.

BIIB

Biogen

$299.72

-2.33 (-0.77%)

15:55
10/25/18
10/25
15:55
10/25/18
15:55

Biogen to host conference call

Chief Medical Officer Sandrock, Jr., discusses Biogen's Alzheimer's investigational therapies as presented at the Alzheimer's Disease Annual Meeting, on a conference call to be held on October 25 at 4:15 pm. Webcast Link

  • 25

    Oct

  • 25

    Oct

BIIB Biogen
$299.72

-2.33 (-0.77%)

10/25/18
PIPR
10/25/18
NO CHANGE
Target $400
PIPR
Overweight
Piper still believes in Biogen's aducanumab after today's BAN2401 data
Piper Jaffray analyst Christopher Raymond maintains an Overweight rating on shares of Biogen with a $400 price target following today's updated subpopulation analysis for BAN2401 Phase 2 data in early Alzheimer's patients. On the surface, the data support the notion that Eisai's reported statistical significant decline in progression was not driven by the APOE4 carrier imbalance in the 10 mg/kg bi-weekly dosing cohort, Raymond tells investors in a research note. The analyst, however, also acknowledges that nuances in the data, coupled with a "rather convoluted presentation," are likely to provide "ample ammunition for A-beta bears" at least until the 2020 full Phase 3 readout for aducanumab. He says that while he still believes in aducanumab, today's BAN2401 readout does not make him any more supportive of that belief. Raymond continues to think Biogen shares "should see lift as we approach that important 2020 read-out." The stock in midday trading is down over 1% to $297.67.
10/24/18
LEER
10/24/18
NO CHANGE
Target $340
LEER
Market Perform
Biogen price target raised to $340 form $328 at Leerink
Leerink analyst Geoffrey Porges raised his price target for Biogen to $340 from $328 after the company reported top and bottom line beats that were driven by strong Spinraza and Tysabri revenue and lower operating expenses. This strong operating performance is somewhat overshadowed by investors' attention to new Alzheimer's disclosures, and the somewhat disappointing pipeline developments revealed during the quarter, he contends. The analyst reiterates a Market Perform rating on the shares.
10/23/18
PIPR
10/23/18
NO CHANGE
Target $400
PIPR
Overweight
Piper a buyer of Biogen shares after 'decent' Q3 report
Piper Jaffray analyst Christopher Raymond said he would characterize Biogen's Q3 report as "a decent top- and bottom-line beat" alongside a "somewhat mixed" pipeline update. Despite some pipeline setbacks, such as BIIB074 and anti-CD40L both having recently failed, he thinks more important pipeline updates are still to come and he remains a buyer of Biogen shares, also citing the stock's "attractive" valuation. Raymond keeps a Overweight rating on the stock with a $400 price target.
10/19/18
10/19/18
DOWNGRADE
Target $341

Market Perform
Bernstein downgrades Biogen to Market Perform on low odds of 2019 outperformance
As previously reported, Bernstein analyst Aaron Gal downgraded Biogen to Market Perform from Outperform, stating that its current stock price roughly reflects the market's recognition of its execution in multiple sclerosis and odds of success in Alzheimer's. He now sees limited further news on Alzheimer's in the near-term and sees potential for downside earning revision on Spinraza and multiple sclerosis competition, Gal tells investors. He lowered his price target on Biogen shares to $341, stating that he sees the stock being less likely to outperform before the start of 2020.

TODAY'S FREE FLY STORIES

GM

General Motors

$37.83

-0.25 (-0.66%)

14:20
03/18/19
03/18
14:20
03/18/19
14:20
Options
Size call write in GM »

Size call write in GM.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 30

    Apr

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
03/18/19
03/18
14:17
03/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
03/18/19
03/18
14:16
03/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$99.59

1.32 (1.34%)

14:10
03/18/19
03/18
14:10
03/18/19
14:10
Options
Walmart calls lead puts 3:1 and implied volatility is at 52-week lows »

Walmart calls lead puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    May

14:10
03/18/19
03/18
14:10
03/18/19
14:10
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

RCII

Rent-A-Center

$21.29

-0.0697 (-0.33%)

14:07
03/18/19
03/18
14:07
03/18/19
14:07
Hot Stocks
LMR Partners reports 7.02% passive stake in Rent-A-Center »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

SKX

Skechers

$32.80

0.22 (0.68%)

14:05
03/18/19
03/18
14:05
03/18/19
14:05
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
03/18/19
03/18
14:05
03/18/19
14:05
General news
Fed funds futures are little changed, though deferred contracts are fractionally lower »

Fed funds futures are…

SNE

Sony

$46.06

-0.195 (-0.42%)

, EA

Electronic Arts

$98.17

-0.82 (-0.83%)

14:03
03/18/19
03/18
14:03
03/18/19
14:03
Hot Stocks
Sony Playstation, EA announce first season of Apex Legends starts March 19 »

Sony (SNE) Playstation…

SNE

Sony

$46.06

-0.195 (-0.42%)

EA

Electronic Arts

$98.17

-0.82 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEVO

Gevo

$2.40

0.11 (4.80%)

14:03
03/18/19
03/18
14:03
03/18/19
14:03
Hot Stocks
Gevo calls out mention of company by Richard Branson »

Gevo's official…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

FLIR

Flir Systems

$49.83

-0.31 (-0.62%)

13:53
03/18/19
03/18
13:53
03/18/19
13:53
Downgrade
Flir Systems rating change  »

Flir Systems downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

RIO

Rio Tinto

$57.03

1.04 (1.86%)

13:49
03/18/19
03/18
13:49
03/18/19
13:49
Periodicals
SEC can pursue Rio Tinto fraud cause, judge says, Reuters reports »

U.S. District Judge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$56.77

-0.14 (-0.25%)

13:45
03/18/19
03/18
13:45
03/18/19
13:45
Options
Cree call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

ON

ON Semiconductor

$21.95

-0.23 (-1.04%)

13:39
03/18/19
03/18
13:39
03/18/19
13:39
Hot Stocks
ON Semiconductor has introduced two new silicon carbide, SiC Mosfet devices »

ON Semiconductor has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,180.85

-4.41 (-0.37%)

, GOOGL

Alphabet Class A

$1,184.84

-6.94 (-0.58%)

13:38
03/18/19
03/18
13:38
03/18/19
13:38
Periodicals
Google denies working with Chinese military, NBCNews reports »

Google denied…

GOOG

Alphabet

$1,180.85

-4.41 (-0.37%)

GOOGL

Alphabet Class A

$1,184.84

-6.94 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 27

    Mar

  • 04

    Apr

  • 27

    Oct

13:35
03/18/19
03/18
13:35
03/18/19
13:35
General news
U.S. corporate bond update: a couple of issuers are jumping in »

U.S. corporate bond…

CCI

Crown Castle

$124.05

-1.03 (-0.82%)

13:35
03/18/19
03/18
13:35
03/18/19
13:35
Options
Crown Castle put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:35
03/18/19
03/18
13:35
03/18/19
13:35
General news
Treasury Option Action: call spread liquidation »

Treasury Option Action:…

FB

Facebook

$159.31

-6.68 (-4.02%)

13:33
03/18/19
03/18
13:33
03/18/19
13:33
Periodicals
Blumenthal wants Facebook probe after live stream of mosque attack, NY Post says »

Senator Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

13:30
03/18/19
03/18
13:30
03/18/19
13:30
Periodicals
U.K. speaker says parliament won't vote again on Brexit deal, WSJ reports »

John Bercow, speaker of…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$281.92

0.61 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNL

Global Net Lease

$18.38

-0.1 (-0.54%)

13:29
03/18/19
03/18
13:29
03/18/19
13:29
Conference/Events
Global Net Lease management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 28

    Mar

  • 15

    Apr

NVRO

Nevro

$44.31

0.56 (1.28%)

13:27
03/18/19
03/18
13:27
03/18/19
13:27
Conference/Events
Nevro management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

NVRO

Nevro

$44.15

0.4 (0.91%)

13:27
03/18/19
03/18
13:27
03/18/19
13:27
Conference/Events
Nevro management to meet with SVB Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

APYX

Apyx Medical

$7.93

0.005 (0.06%)

13:25
03/18/19
03/18
13:25
03/18/19
13:25
Conference/Events
Apyx Medical management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

T

AT&T

$30.77

0.09 (0.29%)

13:24
03/18/19
03/18
13:24
03/18/19
13:24
Periodicals
Kevin Tsujihara ousted as Warner Bros. CEO, CNBC reports »

Kevin Tsujihara has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 24

    Apr

  • 26

    Apr

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.